Enlivex Therapeutics, a Nasdaq-listed company, has announced securing $21 million in debt financing from New York-based institutional investment firm The Lind Partners. The company plans to use the funds to advance its digital asset treasury strategy involving RAIN tokens. Enlivex aims to increase its holdings by approximately 3 billion RAIN tokens, which are part of a decentralized prediction market protocol operating on the Arbitrum network.